Login / Signup

Attempts to Access a Series of Pyrazoles Lead to New Hydrazones with Antifungal Potential against Candida species including Azole-Resistant Strains.

Georgiana NegruLaure KamusElena BîcuSergiu ShovaBoualem SendidFaustine DubarAlina Ghinet
Published in: Molecules (Basel, Switzerland) (2021)
The treatment of benzylidenemalononitriles with phenylhydrazines in refluxing ethanol did not provide pyrazole derivatives, but instead furnished hydrazones. The structure of hydrazones was secured by X-ray analysis. The chemical proof was also obtained by direct reaction of 3,4,5-trimethoxybenzaldehyde with 2,4-dichlorophenylhydrazine. Newly synthesized hydrazones were tested against eight Candida spp. strains in a dose response assay to determine the minimum inhibitory concentration (MIC99). Five compounds were identified as promising antifungal agents against Candida spp. (C. albicans SC5314, C. glabrata, C. tropicalis, C. parapsilosis and C. glabrata (R azoles)), with MIC99 values ranging from 16 to 32 µg/mL and selective antifungal activity over cytotoxicity.
Keyphrases
  • candida albicans
  • biofilm formation
  • escherichia coli
  • molecular docking
  • combination therapy
  • risk assessment
  • magnetic resonance
  • human health
  • mass spectrometry
  • replacement therapy